Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial evaluating peripheral stem cell transplantation for Hodgkin lymphoma or non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by bone marrow or peripheral stem cell transplantation in patients with non-Hodgkin …
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas [Phase 2]
This Phase 2 trial evaluated ibritumomab tiuxetan for non-follicular CD20+ indolent lymphomas; the study was terminated and results were pos…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial of denileukin diftitox for relapsed or refractory non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B [Phase 4]
Phase 4 trial investigating prophylactic entecavir to prevent hepatitis B reactivation in Non-Hodgkin lymphoma patients with resolved hepati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma [Phase 2]
A Phase 2 trial evaluating intensive chemotherapy with rituximab for Burkitt lymphoma and non-Hodgkin lymphoma was terminated, with results …
-
CLINICAL_TRIALS research · 2013-05-20Clinical Trial Update: SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
A completed SWOG trial update documenting collection, analysis, and storage of tissue samples from patients with Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2013-05-20Clinical Trial Update: SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
A completed SWOG trial update describes collecting and storing tissue samples from patients with relapsed or recurrent Non-Hodgkin lymphoma …
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
SWOG-8947 is a completed clinical trial that collected and stored blood samples from patients with previously untreated non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
This clinical trial update indicates that the Phase 1 study of RH-1 in patients with advanced solid tumors and Non-Hodgkin's lymphoma has be…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study evaluating belinostat (PXD101) in combination with bortezomib in adults with advanced solid tumors or lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. [Phase 2]
This open-label, multicenter Phase 2 trial studied CVP chemotherapy followed by an Iodine-131 labeled anti-B1 antibody in previously untreat…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
This report describes results from a Phase 2 trial evaluating combination chemotherapy plus peripheral stem cell transplantation in patients…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma [Phase 2]
Phase 2 trial of Velcade (bortezomib) plus Rituximab for follicular non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study of lenalidomide (Revlimid) for non-Hodgkin lymphoma has completed and posted results in 2013.
-
CLINICAL_TRIALS research · 2013-04-10Clinical Trial Update: Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas
This is a clinical trial update about using a CD20 antibody plus cytokine-induced killer (CIK) cells to treat refractory lymphomas. The curr…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial S0019 evaluating combination chemotherapy with or without rituximab in relapsed or refractory non-Hodgkin lymphoma has been te…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [Phase 2]
A Phase 2 clinical trial update evaluating chemotherapy plus bone marrow transplantation in patients with refractory non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial of Bryostatin-1 in relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia has completed.
-
EMA approval · 2013-03-14EMA Refused: Istodax (romidepsin) — Celgene Europe Ltd.
The EMA refused approval for Istodax (romidepsin) by Celgene Europe Ltd. for lymphoma/non-Hodgkin indications.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial update reports the outcomes of a combination chemotherapy regimen in children with acute lymphoblastic leukemia, osteosar…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating interleukin-2 versus observation after standard therapy in adults with recurrent non-Hodgkin lymphoma has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with monoclonal antibody therapy in newly diagnosed Non-Hodgkin's lymphoma; results were p…
-
FDA approval · 2013-02-26FDA Approved: MOZOBIL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Mozobil (plerixafor) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: PET Study in Patients With Non-Hodgkin Lymphoma
This entry reports the completion of a PET imaging clinical trial in patients with Non-Hodgkin lymphoma. The study involved assessing PET im…